A ccording to the 2008 national projections by the US Census Bureau, there will be 23.8 million people between the ages of 80 to 89 by 2050 -more than double the number of octogenarians recorded in the 2000 census. 1 More than one third (36.5%) of octogenarians have some form of cardiac disease, and 8.1% have aortic stenosis. 1, 2 Although the prevalence of aortic stenosis increases with age, it may only be definitively treated surgically. 3 Octogenarians who have had cardiac surgery have repeatedly been shown to have favorable survivorship. 4, 5 However, most of the previously published data on aortic valve surgery in octogenarians has focused primarily on short-term out-comes. Reported 30-day mortality in octogenarians ranges from 4.8% to 10.1%, compared with 4% to 5% 30-day mortality in patients younger than 80 years, an increase small enough for most clinicians and patients to accept. 6, 7 Although the data are convincing that aortic valve replacement (AVR) carries a satisfactory rate of in-hospital or 30-day mortality in the elderly, there are limited data on long-term outcomes. In the largest study to date, published in 1997, Asimakopoulos et al 8 reported on 1100 octogenarians who underwent AVR. They found actuarial survival to be 68.7% at 5 years and 45.8% at 8 years. Most of the other data on long-term outcomes have been based on small, mostly single-center, retrospective studies, with wide variation reported in terms of the duration of follow-up as well as survival. 9 -13 A number of studies have also examined outcomes of AVR conducted with concomitant CABG surgery. 14 -16 With few exceptions, concomitant CABG surgery does not increase a patient's operative risk. Again, there has been very little reported about the effect that AVRϩCABG has on long-term survival. Considering the mounting evidence for the acceptable perioperative outcomes after AVR with or without concomitant CABG in the elderly, perhaps the fact that as many as one third of patients Ͼ80 years of age with severe aortic stenosis are still denied surgery because of their age 17 is due at least in part to the lack of evidence for long-term outcomes.
We examined the short-and long-term survivorship for a cohort of 7584 consecutive patients undergoing open AVR with and without concomitant CABG from 1987 through 2006 in northern New England.
Methods

Patient Population
We conducted a prospective cohort study of short-and long-term survival associated with consecutive patients undergoing open AVR with or without concomitant CABG surgery at all Northern New England Cardiovascular Disease Study Group centers. For this analysis, we did not include patients having any other concomitant procedures. All patients enrolled in the registry were Ն30 years of age.
Data Collection
Data were obtained from the registries of the Northern New England Cardiovascular Disease Study Group, a voluntary research consortium composed of clinicians, research scientists, and hospital administrators. The goal of the group is to foster the continuous improvement in the quality of care, safety, and effectiveness of cardiovascular interventions through the analysis of process and outcomes data and the timely feedback of these data to the clinicians involved in providing these services. 18 -20 Data are collected on all cardiac surgery procedures in the northern New England region and are periodically validated using administrative data sources. The data collected included patient demographics, comorbid conditions, cardiac history, cardiac anatomy, cardiac function, procedural indication and priority, procedural details, and outcomes. The priority of a patient's intervention was defined as nonelective (urgent/emergent) or elective. "Urgent" indicated that medical factors require the patient to stay in the hospital for the procedure before discharge. "Elective" was defined by medical factors that indicate the need for the procedure but allow the patient to be discharged from the hospital with readmission at a later date. Complete definitions of these variables have been previously published. 21 Institutional review board approval was obtained at each participating medical center. Seven of our 8 member centers' institutional review boards have designated the Northern New England Cardiovascular Disease Study Group as a Quality Improvement Registry, and therefore patient consent was not required. Written patient consent was obtained for the 1 remaining center.
Patient Follow-Up
The outcome measure for this study was all-cause mortality. Mortality through June 30, 2006 , was determined by a probabilistic match of the regional registry to the Social Security Administration's Death Master File (SSA), US Department of Commerce Technology Administration. Linkage was made using a combination of first name, last name, date of birth, date last known alive, last known state of residence, and Social Security number. The sensitivity of the SSA (92.2%) is comparable to the National Death Index among American-born individuals (87% to 98%). 22 Schisterman and Whit-comb 22 reported a drop of nearly 10% in the sensitivity of the SSA file among foreign-born individuals.
Statistical Analysis
Patients were stratified by age categories (Ͻ80, 80 to 84, and Ն85 years), and characteristics were summarized by percentages for categorical variables and means for continuous variables and compared using 2 tests and t tests, respectively. Crude and adjusted survival curves were created according to the nonparametric Kaplan-Meier method. We compared survivorship across age strata for each type of procedure using the Wald test within a Cox proportional hazards model adjusting for the following covariates: sex, ejection fraction, priority, and end-diastolic pressure. We adopted a similar approached for creating adjusted Kaplan-Meier curves as described by Ghali et al 23 and subsequently by Zhang et al. 24 Adjusted Kaplan-Meier curves were created using the statistical program R (version 2.6.0, Foundation for Statistical Computing). All statistical analyses outside of generating our adjusted Kaplan-Meier curves were performed using Stata release 10.0 software (Stata Corp). 25
Results
From November 10, 1987, through June 30, 2006, we studied 7584 consecutive patients who underwent aortic valve surgery. Of these, 51.1% underwent aortic valve surgery alone (AVR) and 48.9% had concomitant coronary artery bypass graft surgery (AVRϩCABG). During 39 835 person-years of total follow-up, there were 2877 deaths.
Isolated Aortic Valve Surgery
In the AVR group, there were 3304 patients Ͻ80 years of age, 419 patients ages 80 to 84 years, and 156 patients Ն85 years of age (24 patients were 90 years or older). Increasing age was associated with female sex, more vascular disease and congestive heart failure, and procedural urgency ( Table 1) . Patients in this group were less likely to have diabetes.
Patients undergoing AVR were more likely to have tissue rather than mechanical valves ( Table 2 ). The use of tissue valves increased with age (58.3% among patients Ͻ80, 88.9% in the 80 to 84 age group, and 89.3% among patients Ն85, PϽ0.001). Nearly 100% of patients had their aortic valve replaced.
Perioperatively, older age was associated with increased risk of stroke, atrial fibrillation, and longer length of stay ( Table 3 ).
The 30-day mortality among this cohort was 3.7% for patients Ͻ80, 6.7% in the 80 to 84 age group, and 11.7% in those ages Ն85 (PϽ0.001). Crude survivorship through 12 years beyond the index admission is detailed in Table 4 . For patients Ͻ80 years, median survivorship was 11.5 years ( Figure 1 ). Median survivorship decreased to 6.8 years among patients 80 to 84 years and 6.2 years among those Ն85 years. Survivorship was significantly different across strata of age (P trend Ͻ0.001.
AVR؉CABG
Among AVRϩCABG patients, there were 2890 patients Ͻ80 years of age, 577 patients ages 80 to 84 years, and 238 patients Ͼ85 years of age (22 patients were older than 90). Increasing age in this group was significantly associated with female sex, left main stenosis, procedural urgency, congestive heart failure, number of diseased vessels, and lower ejection S128 Circulation September 15, 2009 fraction ( Table 1) . Patients over age 80 in this group were less likely to have diabetes and chronic obstructive pulmonary disease. Most patients undergoing AVRϩCABG had an internal mammary artery (Table 2) , followed by a saphenous vein.
Patients were more likely to have tissue rather than mechanical valves. The use of tissue valves increased with age (73.9% among patients Ͻ80, 92.6% in the 80 to 84 age group, and 97.4% among patients Ն85, PϽ0.001). Nearly 100% of patients had their aortic valve replaced. 
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Perioperatively, older age was associated with increased risk of atrial fibrillation and longer length of stay (Table 3) .
Among patients undergoing AVRϩCABG, 6.2% of patients Ͻ80 years died within 30 days, 9.4% among those 80 to 84, and 8.5% of patients Ն85 years (Pϭ0.01). Survival over the entire follow-up period favored the younger patients (Table 4 ). For AVRϩCABG patients, median survivorship followed a similar trend, with patients Ͻ80 surviving 9.4 years, patients 80 to 84, 6.8 years, and patients older than 85, 7.1 years (Figure 2) . Survivorship was significantly different across strata of age (P trend Ͻ0.001.
Discussion
In our study of 7584 patients, including 815 over the age of 80, we found that short-and long-term survival was favorable across all age groups. Specifically, more than half of the patients undergoing aortic valve procedures were alive 6 years after surgery. Among patients Ͻ80 years, survivorship favored those undergoing isolated AVR procedures, but among octogenarians, concomitant CABG surgery did not result in reduced survivorship. These findings mirror the life expectancy among the general population, which show an additional 7 years of life among those ages 80 to 84 years and 5 years among those ages Ն85 years. 26 The natural history of untreated severe aortic stenosis strongly suggests the need for surgical intervention. In 1968, Ross and Braunwald reported that the average survival in aortic stenosis patients is 3 years after the onset of angina or syncope and only 1 1 ⁄2 years after onset of heart failure. 27 Thirty years after Ross and Braunwald's publication, the American College of Cardiology/American Heart Associa-tion guidelines estimate a patient's survival from initial aortic stenosis symptoms to be less than 2 to 3 years. 3 Varadarajan et al 2 examined survival among 277 patients Ͼ80 years of age presenting with severe aortic stenosis; 80 underwent AVR. Survival was significantly improved in the surgical patients. After AVR, 1-year, 2-year, and 5-year survival was 87%, 78%, and 68%, compared with 52%, 40%, and 22%, respectively, in the patients who were managed medically, demonstrating that surgery is the best alternative for survival in octogenarians with severe symptoms. In their study of 103 octogenarians with severe, symptomatic aortic stenosis, Kojodjojo et al 28 showed that patients who refused AVR had a greater than12-fold in-hospital mortality rate relative to the cohort of patients who underwent surgery.
Our findings agree with previous reports concerning octogenarians undergoing aortic valve surgery. In 1997, Asimakopoulos et al 8 
reviewed United Kingdom Heart Valve
Registry data from 1100 patients Ͼ80 years of age who underwent AVR from January 1986 to December 1995. They reported 30-day mortality as 6.6% with actuarial survival of 89%, 79.3%, 68.7%, and 45.8% at 1, 3, 5, and 8 years, respectively. Langanay et al 6 reviewed in-hospital data for 771 octogenarians undergoing AVR between 1978 to 2003. The authors reported a 10.1% operative mortality, yet did not follow patients beyond their index admission. Our index admission mortality findings among patients undergoing isolated AVR are in agreement with Langanay (7.6% among 80 to 84 years, 10.3% among Ն85 years). Among studies reporting survivorship beyond of the index admission, fiveyear survival ranged from 56% to 64%. 13, 29, 30 Our series is consistent with these reports, with 6-year survival of 54.7% in 13 reported that concomitant CABG improved both 30-day (odds ratio, 0.3; 95% confidence interval [CI], 0.08 to 0.083; Pϭ0.017) and long-term survival (hazards ratio, 0.7; 95% CI, 0.47 to 0.96; Pϭ0.020). In contrast, Roberts et al 16 in their series of 196 octogenarians found that simultaneous CABG had no effect on 60-day mortality (relative risk, 0.96; 95% CI, 0.54 to 1.70) and a statistically insignificant increased median late survival: 7.4 years (95% CI, 6.4 to 13.3) for patients after AVRϩCABG versus 6 years (95% CI, 5.4 to 8.9) for patients after AVR. Our present findings are similar to those of Gulbins et al, 31 who showed that in-hospital mortality rates were higher among patients having AVRϩCABG versus those undergoing AVR (10% versus 4%, PϽ0.05). Gulbins et al 31 suggested that the additional risk of mortality was acceptable, given a lower observed mortality rate relative to that predicted through the use of Euroscore.
Recent publications have highlighted survivorship among patients undergoing percutaneous aortic valve replacement. 32 Grossi et al 32 reported the inability for a commonly used risk prediction model, the Euroscore, to predict accurately the risk of mortality among patients undergoing these procedures. The authors focused their study among high risk patients, that is, those with a Euroscore of Ն7. Interestingly, 44% of their patients were Ն80 years. Our regional collaborative does not have any experience in performing aortic valve surgery percutaneously. As such, we cannot comment on the generalizability of our findings to patients undergoing percutaneous procedures.
We acknowledge several limitations to the current study. First, from a patient's perspective, functionality after the surgery may be more important than survivorship alone. Using the Seattle Angina Questionnaire, Huber et al 33 interviewed 136 patients who were Ͼ80 years of age at the time of cardiac surgery (isolated CABG, AVR, or AVRϩCABG). They found that 95% lived in their own homes, and 93% reported that they had experienced no reduction to their quality of life. Kolh et al 12 interviewed 61 long-term survivors of AVR and found that 92% of patients believed that having heart surgery at age Ͼ80 was a "good choice," with 88% of patients feeling "as good or better" than they had before surgery. Additionally, Maillet et al 34 Third, we report findings from our prospective cohort experience, and as such are unable to account for any unknown confounding factors or selection of patients referred for surgery. The decision for the type of procedures was at the discretion of the patient and his or her provider. We do not have information on patients who were turned down for AVR, CABG, or both. Because of the known extremely poor prognosis for patients with severe aortic stenosis who do not undergo AVR, it would be impossible to design an ethical randomized trial.
In conclusion, this study presents the largest experience to date of octogenarians undergoing surgical treatment of aortic stenosis. As the number of octogenarians continues to increase in the United States, so too does the number of elderly patients with severe aortic stenosis. We have demonstrated that aortic valve replacement with or without concomitant CABG is a safe and effective option for elderly patients with severe aortic stenosis. Survivorship in this cohort is favorable, with more than half the patients surviving more than 6 years after their surgery, a finding mirroring the general population life tables. Although concomitant CABG adds a slight mortality risk in the immediate postoperative period, it does not appreciably affect long-term survival among patients older than 80 years.
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